First Allied Advisory Services’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $50K | Sell |
17,000
-14,000
| -45% | -$41.2K | ﹤0.01% | 1165 |
|
|
2020
Q2 | $143K | Hold |
31,000
| – | – | 0.01% | 1045 |
|
|
2020
Q1 | $119K | Buy |
31,000
+2,000
| +7% | +$7.68K | 0.01% | 991 |
|
|
2019
Q4 | $109K | Hold |
29,000
| – | – | ﹤0.01% | 1170 |
|
|
2019
Q3 | $154K | Hold |
29,000
| – | – | 0.01% | 1155 |
|
|
2019
Q2 | $111K | Buy |
29,000
+2,000
| +7% | +$7.66K | ﹤0.01% | 1157 |
|
|
2019
Q1 | $138K | Hold |
27,000
| – | – | ﹤0.01% | 1094 |
|
|
2018
Q4 | $52K | Buy |
27,000
+1,000
| +4% | +$1.93K | ﹤0.01% | 1045 |
|
|
2018
Q3 | $98K | Hold |
26,000
| – | – | ﹤0.01% | 1147 |
|
|
2018
Q2 | $81K | Hold |
26,000
| – | – | ﹤0.01% | 1120 |
|
|
2018
Q1 | $62K | Hold |
26,000
| – | – | ﹤0.01% | 1144 |
|
|
2017
Q4 | $102K | Hold |
26,000
| – | – | ﹤0.01% | 1198 |
|
|
2017
Q3 | $66K | Hold |
26,000
| – | – | ﹤0.01% | 1100 |
|
|
2017
Q2 | $72K | Buy |
+26,000
| New | +$72K | ﹤0.01% | 1113 |
|